Wendell David Associates’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,300
Closed -$233K – 155
2026
Q2
$233K Buy
+3,300
New +$178K 0.02% 149
2025
Q2
– Sell
-3,600
Closed -$211K – 152
2025
Q1
$211K Hold
3,600
– – 0.02% 147
2024
Q4
$259K Sell
3,600
-1,000
-22% -$73.4K 0.03% 145
2024
Q3
$368K Hold
4,600
– – 0.04% 135
2024
Q2
$330K Hold
4,600
– – 0.03% 133
2024
Q1
$324K Hold
4,600
– – 0.03% 140
2023
Q4
$355K Hold
4,600
– – 0.04% 130
2023
Q3
$313K Hold
4,600
– – 0.04% 130
2023
Q2
$375K Hold
4,600
– – 0.04% 121
2023
Q1
$341K Hold
4,600
– – 0.04% 120
2022
Q4
$381K Hold
4,600
– – 0.05% 120
2022
Q3
$327K Sell
4,600
-400
-8% -$34.6K 0.04% 120
2022
Q2
$433K Hold
5,000
– – 0.06% 114
2022
Q1
$541K Hold
5,000
– – 0.06% 110
2021
Q4
$647K Hold
5,000
– – 0.07% 110
2021
Q3
$606K Sell
5,000
-400
-7% -$48.7K 0.07% 106
2021
Q2
$608K Sell
5,400
-600
-10% -$63.2K 0.07% 107
2021
Q1
$573K Hold
6,000
– – 0.07% 102
2020
Q4
$476K Hold
6,000
– – 0.06% 109
2020
Q3
$372K Hold
6,000
– – 0.05% 116
2020
Q2
$396K Hold
6,000
– – 0.06% 114
2020
Q1
$284K Hold
6,000
– – 0.05% 124
2019
Q4
$329K Hold
6,000
– – 0.05% 132
2019
Q3
$294K Hold
6,000
– – 0.04% 132
2019
Q2
$313K Hold
6,000
– – 0.05% 132
2019
Q1
$298K Hold
6,000
– – 0.05% 134
2018
Q4
$217K Hold
6,000
– – 0.04% 140
2018
Q3
$306K Hold
6,000
– – 0.05% 134
2018
Q2
$222K Hold
6,000
– – 0.04% 147
2018
Q1
$227K Buy
+6,000
New +$212K 0.04% 147

Other funds holding TECH

Wendell David Associates's TECH Position: Q3 2026 in Review

Wendell David Associates sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 3,300 shares — an estimated $233K sold.

Wendell David Associates first reported a position in TECH in Q1 2018 and held it in 30 quarters. The position peaked at $647K in Q4 2021. 128 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Wendell David Associates reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Wendell David Associates sold 3,300 Bio-Techne shares in Q3 2026, an estimated $233K.
  • Wendell David Associates first reported a position in Bio-Techne in Q1 2018 and held it in 30 quarters.
  • Wendell David Associates's Bio-Techne position peaked at $647K in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Wendell David Associates's 13F filing for Q3 2026, filed 27 Oct 2026.